Table 2.
univariable analysis | multivariable analysis | ||||
---|---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | ||
Age | per 10 years older | 1.32 (1.03–1.69) | 0.026* | ||
Gender | male (vs. female) | 1.17 (0.61–2.25) | 0.639 | ||
Smoking status | never smoker (vs. current/past) | 0.66 (0.20–2.19) | 0.492 | ||
Karnofsky Performance Status | per 10 higher | 0.76 (0.62–0.92) | 0.005* | 0.76 (0.62–0.98) | 0.030* |
UICC stage | IVA-B (vs. I-III) | 1.87 (1.01–3.47) | 0.045* | ||
Tumor grade | G3 (vs. G1-G2) | 0.91 (0.54–1.54) | 0.731 | ||
Hemoglobin | per 1 g/dL higher | 0.89 (0.77–1.04) | 0.143 | ||
log NLR | per 1 log NLR higher | 1.81 (1.16–2.81) | 0.009* | 1.58 (1.01–2.47) | 0.043* |
log PLR | per 1 log PLR higher | 1.62 (0.99–2.63) | 0.054 |
CI confidence interval, G tumor grade, HR hazard ratio, log NLR natural logarithm of neutrophil-to-lymphocyte ratio, log PLR natural logarithm of platelet-to-lymphocyte ratio, UICC Union for International Cancer Control; *statistically significant